Zhang Financial’s Avita Medical RCEL Stock Holding History

Zhang Financial’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,465	Closed	-$76K	–	94
2020 Q1	$76K	Buy	+2,465	New	+$102K	0.03%	89

Other funds holding RCEL

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Zhang Financial's RCEL Position: Q2 2020 in Review

Zhang Financial sold out of Avita Medical (RCEL) in Q2 2020, closing a stake of 2,465 shares — an estimated $76K sold.

Zhang Financial first reported a position in RCEL in Q1 2020 and held it in 1 quarter. The position peaked at $76K in Q1 2020. 34 funds tracked by Wall St. Rank hold RCEL as of Q2 2020.

Zhang Financial reported no remaining Avita Medical position as of Q2 2020 after selling out during the quarter.
Zhang Financial sold 2,465 Avita Medical shares in Q2 2020, an estimated $76K.
Zhang Financial first reported a position in Avita Medical in Q1 2020 and held it in 1 quarter.
Zhang Financial's Avita Medical position peaked at $76K in Q1 2020.
34 funds tracked by Wall St. Rank held Avita Medical as of Q2 2020.

Based on Zhang Financial's 13F filing for Q2 2020, filed 23 Jul 2020.